Riskpilot← Back to searchSign inGet full accessINCLINIQUE AS
ASActiveOrg 999141226Austbøvegen 15, 5542 KarmsundOther human health activities n.e.c. · NACE 8699Est. 20123 employees
Revenue 2024
NOK 1,2M
-29% vs 2023
EBITDA margin
-21.6%
-321% vs 2023
Equity ratio
5.5%
Financial strength
Net profit 2024
NOK -248K
-160% vs 2023
| Revenue | NOK 1,2M | -29% |
| EBITDA | NOK -249K | -321% |
| Net profit | NOK -248K | -160% |
| Total assets | NOK 247K | -57% |
| Equity | NOK 14K | -95% |
| Employees | 3 | — |
Legal name
INCLINIQUE AS
Org number
999141226
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
14. november 2012
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder og styrets leder i fellesskap.
Company purpose
Medisinske behandlinger, hud og kroppspleie, salg og utleie, kursvirksomhet. I tillegg driver selskapet med fremleie av fast eiendom, samt alt hva hermed står i forbindelse, herunder å delta i selskaper med samme formål.
Address
Austbøvegen 15, 5542 Karmsund
Phone
+4795041666
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 426 | 2 068 | 2 160 | 1 626 | 1 154 |
| Staff expenses | −466 | −486 | −1 139 | −637 | −422 |
| EBITDA | 546 | 274 | −299 | −59 | −249 |
| Depreciation & amort. | −43 | −43 | −43 | −42 | −3 |
| EBIT | 503 | 232 | −342 | −101 | −252 |
| Net financials | −2 | 5 | 4 | 6 | 4 |
| Profit before tax | 501 | 237 | −338 | −95 | −248 |
| Tax | 74 | 50 | −0 | −0 | −0 |
| Net profit | 427 | 186 | −338 | −95 | −248 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 923 | 1 196 | 790 | 582 | 247 |
| Equity | 509 | 695 | 357 | 261 | 14 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 414 | 501 | 433 | 320 | 234 |
| Total debt | 414 | 501 | 433 | 320 | 234 |
EBITDA margin
-21.6%
This company
15.8%
Market median
-237% vs market
20202024
Equity ratio
5.5%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
-1830.7%
This company
18.4%
Market median
-10049% vs market
20202024
Net profit margin
-21.5%
This company
8.1%
Market median
-365% vs market
20202024
Asset turnover
4.66×
This company
1.12×
Market median
+316% vs market
20202024
Debt / equity
17.26×
This company
0.62×
Market median
-2684% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Former (1) | ||
| Board of Directors | 2016 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 49% | 49% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Max Beauty As
INCLINIQUE AS Board members of INCLINIQUE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hilde Kristin Aase | Chairman | 0 companies |
| Ole Sævild | Board of Directors | 0 companies |